Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

208

Participants

Timeline

Start Date

June 21, 2022

Primary Completion Date

December 21, 2025

Study Completion Date

December 21, 2025

Conditions
Breast Ductal Carcinoma In SituInvasive Breast Carcinoma
Interventions
DRUG

Agent Affecting Integumentary System

Apply Miaderm

OTHER

Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment

Apply to skin

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

91010

City of Hope Medical Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER